Segall Bryant & Hamill’s Integra LifeSciences IART Stock Holding History

Segall Bryant & Hamill’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-53,393	Closed	-$1.89M	–	425
2024 Q1	$1.89M	Sell	53,393 -117,396	-69%	-$4.16M	0.04%	279
2023 Q4	$7.44M	Buy	170,789 +4,865	+3%	+$212K	0.14%	228
2023 Q3	$6.34M	Sell	165,924 -9,541	-5%	-$364K	0.07%	285
2023 Q2	$7.22M	Buy	175,465 +463	+0.3%	+$19K	0.08%	288
2023 Q1	$10M	Sell	175,002 -77,203	-31%	-$4.43M	0.11%	230
2022 Q4	$14.1M	Buy	252,205 +14,274	+6%	+$800K	0.16%	176
2022 Q3	$10.1M	Buy	237,931 +31,566	+15%	+$1.34M	0.12%	205
2022 Q2	$11.1M	Buy	206,365 +47,391	+30%	+$2.56M	0.13%	182
2022 Q1	$10.2M	Buy	158,974 +199	+0.1%	+$12.8K	0.1%	216
2021 Q4	$10.6M	Buy	158,775 +48,754	+44%	+$3.27M	0.1%	207
2021 Q3	$7.54M	Sell	110,021 -65,161	-37%	-$4.46M	0.07%	251
2021 Q2	$12M	Buy	175,182 +15,525	+10%	+$1.06M	0.12%	195
2021 Q1	$11M	Sell	159,657 -23,286	-13%	-$1.61M	0.11%	199
2020 Q4	$11.9M	Buy	182,943 +13,831	+8%	+$898K	0.13%	173
2020 Q3	$7.99M	Buy	169,112 +54,106	+47%	+$2.56M	0.11%	190
2020 Q2	$5.4M	Buy	115,006 +6,010	+6%	+$282K	0.09%	208
2020 Q1	$4.87M	Sell	108,996 -7,531	-6%	-$336K	0.1%	199
2019 Q4	$6.79M	Buy	116,527 +1,947	+2%	+$113K	0.11%	195
2019 Q3	$6.88M	Sell	114,580 -26,062	-19%	-$1.57M	0.11%	223
2019 Q2	$7.86M	Sell	140,642 -10,721	-7%	-$599K	0.12%	209
2019 Q1	$8.43M	Buy	151,363 +1,626	+1%	+$90.6K	0.13%	199
2018 Q4	$6.75M	Buy	149,737 +16,021	+12%	+$723K	0.12%	221
2018 Q3	$8.81M	Buy	133,716 +10,079	+8%	+$664K	0.13%	211
2018 Q2	$7.96M	Buy	123,637 +5,017	+4%	+$323K	0.12%	221
2018 Q1	$6.56M	Sell	118,620 -7,372	-6%	-$408K	0.15%	156
2017 Q4	$6.03M	Buy	125,992 +13,472	+12%	+$645K	0.13%	174
2017 Q3	$5.68M	Buy	112,520 +19,486	+21%	+$984K	0.13%	170
2017 Q2	$5.07M	Buy	+93,034	New	+$5.07M	0.12%	186